![Pietro Di Ciaccio Profile](https://pbs.twimg.com/profile_images/1430419081702744064/s2o6WPuZ_x96.png)
Pietro Di Ciaccio
@prpdiciaccio
Followers
323
Following
464
Statuses
630
Clinical haematologist and haematopathologist in Canberra, Australia. Lymphoma doc. Chair, Australasian Lymphoma Alliance.
Joined April 2020
#MedTwitter was formerly a wonderful fertile ground for learning and collaboration. Now it is buried under the refuse of what Twitter has become. I’ll be over at the other place musing on KM curves and cells of origin 🙂 Hope to see you there @prpdiciaccio.bsky.social #lymsm
3
0
3
RT @tobyeyre82: congratulations to the EA4151 investigators for a superb RCT - v important results #ASH2024 #MCL
0
14
0
@samyamshon @RahulBanerjeeMD I wonder how you feel about medical writers? At one level, I wonder what the difference truly is sadly @Eddie_Cliff
2
0
5
Small numbers. Encouraging activity.
Dara+DA-EPOCH in 1L PBL #ASH24: - 15 pts, 1° outcome = ability to give 3 cycles - 11 pts able to get 3 cycles, 85% dose density - 10 pts CR, 1-yr PFS 78%, OS 85% I've used this regimen to good effect; question is if to continue maintenance dara. Phase II ongoing. #lymsm
0
0
2
@geltamo @AnnaSureda5 16% did not receive infusion Median vein to vein 37 days Hopefully this is improving #lymsm
0
0
1
RT @Dr_Daniel_Molin: Baech et al: Congestive heart failure after Hodgkin treatment in Sweden. Pts treated with ≤200 mg/m2 anthracyclines h…
0
12
0
I must say, I’ve always found the results of POLARIX underwhelming. Hoping COO subsets will be presented at #ASH24 #lymsm
Salles et al 5 yr results of POLARIX 1L RCT PolaRCHP vs RCHOP in IPI 2-5 DLBCL 5-year PFS estimates 64.2% vs 59.1% HR 0.78; 95% CI: 0.623-0.980 5-year OS 82.2% vs 79.6% not significant #ASH2024 #lymsm
0
3
5
RT @tobyeyre82: Salles et al 5 yr results of POLARIX 1L RCT PolaRCHP vs RCHOP in IPI 2-5 DLBCL 5-year PFS estimates 64.2% vs 59.1% HR 0.7…
0
26
0
@tobyeyre82 I’m curious what you think this means for second line MCL treatment. We can only access CART in third line.
0
0
1
RT @chanyooncheah: @LaRDRregistry chair @OpatStephen summarising the major wins of the Lymphoma registry at #BLOOD24 -now>8000 cases cover…
0
6
0
RT @chanyooncheah: @AustralasianLy1 @LaRDRregistry @lymphomaOz @AustralasianLy1 chair @prp_diciaccio presenting on the wonderful achievemen…
0
5
0
Thanks everyone who attended the Lymphoma Breakfast this morning at Blood 2024. An honour to share the stage with incredible colleagues and inspirational consumer advocates @AustralasianLy1 @lymphomaOz
1
0
12
RT @majorajay: Update on older adults in S1826 @DrAEvens #ISHL13 (T077): - 99 pts age >60y, median f/u now 2.1 yrs - 2-yr PFS 89% N-AVD (64…
0
18
0
RT @LaRDRregistry: Confirmed program for the Lymphoma Breakfast Meeting 2024! Chairs: @AllisonBarra1, Joel Wight @AustralasianLy1, @LaRDRr…
0
1
0